| abstract |
It is intended to provide a melanogenesis inhibitory composition having a high safety and an elevated efficacy when administered internally (oral administration, injection, etc.) or externally (application to the skin, patch, etc.), and a whitening method with the use of this melanogenesis inhibitory composition. Namely, a melanogenesis inhibitory composition characterized by containing the cellular contents of an acetic acid bacterium as the active ingredient; and a whitening method characterized by comprising internally and/or externally administering the melanogenesis inhibitory composition. |